https://orcid.org/0000-0002-2205-1453
References
- Gorbalenya AE, Snijder EJ. Viral cysteine proteinases. Perspec Drug Discov 1996;6:64–86.
- Sánchez-Vizcaíno JM, Mur L, Gomez-Villamandos JC, Carrasco L. An update on the epidemiology and pathology of African swine fever. J Comp Pathol 2015;152:9–21.
- Wang T, Sun Y, Qiu HJ. African swine fever: an unprecedented disaster and challenge to China. Infect Dis Poverty 2018;7:111.
- Sánchez EG, Pérez-Núñez D, Revilla Y. Development of vaccines against African swine fever virus. Virus Res 2019;265:150–5.
- African Swine Fever (ASF). Report N° 18: May 10–23, 2019 [Internet]. World Organisation for Animal Health; c2019 [updated 2019 May 10]. [cited 2019 May 23]. Available from: http://www.oie.int/fileadmin/Home/eng/Animal_Health_in_the_World/docs/pdf/Disease_cards/ASF/Report_18_Current_situation_of_ASF_mic.pdf.
- Dixon LK, Escribano JM, Martins C, et al., Eds. London, UK, Elsevier/Academic Press; 2005, pp. 135–143.
- Andres G, Alejo A, Simon-Mateo C, Salas ML. African swine fever virus protease, a new viral member of the SUMO-1-specific protease family. J Biol Chem 2001;276:780–7.
- Coelho J, Martins C, Ferreira F, Leitão A. African swine fever virus ORF P1192R codes for a functional type II DNA topoisomerase. Virology 2015;474:82–93.
- Freitas FB, Frouco G, Martins C, et al. In vitro inhibition of African swine fever virus-topoisomerase II disrupts viral replication. Antiviral Res 2016;134:34–41.
- Coelho J, Ferreira F, Martins C, Leitão A. Functional characterization and inhibition of the type II DNA topoisomerase coded by African swine fever virus. Virology 2016;493:209–16.
- Mottola C, Freitas FB, Simões M, et al. In vitro antiviral activity of fluoroquinolones against African swine fever virus. Vet. Microbiol 2013;165:86–94.
- Hakobyan A, Arabyan E, Avetisyan A, et al. Apigenin inhibits African swine fever virus infection in vitro. Arch Virol 2016;161:3445–53.
- Arabyan E, Hakobyan A, Kotsinyan A, et al. Genistein inhibits African swine fever virus replication in vitro by disrupting viral DNA synthesis. Antivir. Res 2018;156:128–37.
- Hakobyan A, Arabyan E, Kotsinyan A, et al. Zakaryan Inhibition of African swine fever virus infection by genkwanin. Antiviral Res 2019;167:78–82.
- Lin H, Lan J, Guan M, et al. Spectroscopic investigation of interaction between mangiferin and bovine serum albumin. Spectrochim Acta A Mol. Biomol. Spectrosc 2009;73:936–41.
- Pohjala L, Tammela P. Aggregating behavior of phenolic compounds–a source of false bioassay results? Molecules (Basel, Switzerland) 2012;17:10774–90.
- Zakaryan H, Arabyan E, Oo A, Zandi K. Flavonoids: promising natural compounds against viral infections. Arch. Virol 2017;162:2539–51.
- Yang L, Lin J, Zhou B, et al. Activity of compounds from Taxillus sutchuenensis as inhibitors of HCV NS3 serine protease. Natural Product Research 2017;31:487–91.
- Kiat TS, Pippen R, Yusof R, et al. Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue‐2 virus NS3 protease. Bioorg Med Chem Lett 2006;16:3337–40.
- Semwal DK, Semwal RB, Combrinck S, Viljoen A. Myricetin: a dietary molecule with diverse biological activities. Nutrients 2016;8:90.
- Pasetto S, Pardi V, Murata RM. Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model. PloS One 2014;9:e115323.